A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : NET / neuroendocrine tumor

[Related PubMed/MEDLINE]
Total Number of Papers: 964
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   NET  (>> Co-occurring Abbreviation)
Long Form:   neuroendocrine tumor
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 A Case of Streptozocin Monotherapy for Unresectable Duodenal Neuroendocrine Tumor G2. STZ
2019 A unique case of ectopic Cushing's syndrome from a thymic neuroendocrine carcinoma. ACTH, CS, EAS
2019 Aggressive resection of neuroendocrine tumor (NET) liver metastases: NET neutral or gain? ---
2019 Atypical bronchial carcinoid with postobstructive mycobacterial infection: case report and review of literature. CT, NTM
2019 Biliary Neuroendocrine Neoplasms: Clinical Profiles, Management, and Analysis of Prognostic Factors. MANEC, NEC, NENs
2019 Carcinoid heart disease involving the left heart: a case report and biomarker analysis. DOPA-PET, H-FABP, IL-8, PFO, sST2
2019 Carcinoid tumors of the thymus and Cushing's syndrome: Clinicopathologic features and current best evidence regarding the cell of origin of these unusual neoplasms. ACTH, ATC, CRH, CS, TC
2019 Clinical routine use of virtual monochromatic datasets based on spectral CT in patients with hypervascularized abdominal tumors - evaluation of effectiveness and efficiency. CNR, CT, HCC, RCC, SNR, VMI
2019 Colon Neuroendocrine Tumors: A New Lymph Node Staging Classification. CI
10  2019 Comparison of temozolomide-capecitabine to 5-fluorouracile-dacarbazine in 247 patients with advanced digestive neuroendocrine tumors using propensity score analyses. 5-FU, CAP, PFS, TEM
11  2019 Complementary and alternative medicine use during chemotherapy for neuroendocrine tumours. CAM
12  2019 Current status of functional imaging in neuroblastoma, pheochromocytoma, and paraganglioma disease. NB, PCC, PGL
13  2019 Gastric Neuroendocrine Tumor and Duodenal Gastrinoma With Chronic Autoimmune Atrophic Gastritis. CAG
14  2019 Hemobilia following Percutaneous Liver Biopsy in the Setting of Malignancy (with Video): Diagnosis and Management of a Rare Cause of Upper Gastrointestinal Bleeding. ---
15  2019 Influence of lanreotide on uptake of 68Ga-DOTATATE in patients with neuroendocrine tumours: a prospective intra-patient evaluation. ---
16  2019 Intratumoral Hemorrhage of Liver Metastasis from a Rectal Neuroendocrine Tumor. CT
17  2019 Liver metastases of neuroendocrine tumors: is it possible to diagnose different histologic subtypes depending on multiphasic CT features? CT, ROI, T-A, T-L
18  2019 Long-term outcomes according to additional treatments after endoscopic resection for rectal small neuroendocrine tumors. EMR, ER
19  2019 Neuroendocrine tumor of the appendix: Twelve years of results from a single institution. ---
20  2019 Outcomes After Transarterial Embolization of Neuroendocrine Tumor Liver Metastases Using Spherical Particles of Different Sizes. TAE
21  2019 Outcomes and toxicity following Yttrium-90 radioembolization for hepatic metastases from neuroendocrine tumors-a single-institution experience. ---
22  2019 Peptide Receptor Radionuclide Therapy for Patients With Advanced Lung Carcinoids. FDA, NEN, NETTER-1, PRRT
23  2019 Personalized 177Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: initial results from the P-PRRT trial. IA, PRRT
24  2019 Primary cystic neuroendocrine tumor of the liver: case report PHNET
25  2019 Proliferation Marker (Ki67) in Sub-Categorization of Neuroendocrine Tumours of the Lung. ---
26  2019 Real-World Treatment Patterns and Clinical Outcomes in Advanced Gastrointestinal Neuroendocrine Tumors (GI NET): A Multicenter Retrospective Chart Review Study. GI, GI NET, LDT, OS, SSA
27  2019 Risk of Primary Neuroendocrine Pancreatic Tumor After a First Primary Cancer: A US Population-Based Study. FPC
28  2019 Salvage peptide receptor radionuclide therapy with [177Lu-DOTA,Tyr3]octreotate in patients with bronchial and gastroenteropancreatic neuroendocrine tumours. AML, GEP-NET, I-PRRT, MDS, OS, PFS, R-PRRT, RR-PRRT
29  2019 Surgery Provides Long-Term Survival in Patients with Metastatic Neuroendocrine Tumors Undergoing Resection for Non-Hormonal Symptoms. NH
30  2019 The safety of lanreotide for neuroendocrine tumor. ---
31  2019 Therapeutic sequences in patients with grade 1-2 neuroendocrine tumors (NET): an observational multicenter study from the ELIOS group. PFS, PRRT, SSA
32  2019 Unmet Needs in High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms (WHO G3). GEP, NEC, NEN
33  2019 Value of Tumor Growth Rate (TGR) as an Early Biomarker Predictor of Patients' Outcome in Neuroendocrine Tumors (NET)-The GREPONET Study. CI, HR, NETs, PFS, pts, ST, TGR, TGR3m, WW
34  2019 Web-based personalised information and support for patients with a neuroendocrine tumour: randomised controlled trial. QLQ, TAM, WINS
35  2019 [Pancreatic neuroendocrine tumors : Current treatment concepts]. pNEN
36  2018 18F-FDG Uptake in Well-Differentiated Neuroendocrine Tumors Correlates with Both Ki-67 and VHL Pathway Inactivation. CA9, GLUT1, NEN
37  2018 68-Gallium DOTATATE scanning in symptomatic patients with negative anatomic imaging but suspected neuroendocrine tumor. PET
38  2018 68Ga-DOTATOC and 18F-FDG PET/CT for identifying the primary lesions of suspected and metastatic neuroendocrine tumors: Aprospective study in Taiwan. ---
39  2018 A 10-year History of a Diminutive Rectal Neuroendocrine Tumor. ---
40  2018 A liquid biopsy for bronchopulmonary/lung carcinoid diagnosis. BP, PCA
41  2018 A Rare Cause of Abdominal Pain and Mass in an 18-Year-Old Patient: A Diagnostic Dilemma. EGD, EUS, NSE
42  2018 A retrospective case study of sunitinib treatment in three patients with Von Hippel-Lindau disease. cRCCs, CT, MRI, VHL
43  2018 A small, well-differentiated rectal neuroendocrine tumor with multiple lymph node metastases: A case report. ---
44  2018 Accuracy of apparent diffusion coefficient in differentiating pancreatic neuroendocrine tumour from intrapancreatic accessory spleen. ADC, IPAS, ROC
45  2018 Additional hepatic 166Ho-radioembolization in patients with neuroendocrine tumours treated with 177Lu-DOTATATE; a single center, interventional, non-randomized, non-comparative, open label, phase II study (HEPAR PLUS trial). 166Ho-RE, 177Lu, PRRT
46  2018 Age- and sex-dependent changes in sympathetic activity of the left ventricular apex assessed by 18F-DOPA PET imaging. DOPA
47  2018 An Advanced Well-differentiated Pancreatic Neuroendocrine Carcinoma (NET-G3) Associated with Von Hippel-Lindau Disease. VHL
48  2018 Aspects regarding nomenclature, classification and pathology of neuroendocrine neoplasms of the digestive system - a review. ENETS, NEC, NENs, WHO
49  2018 Assessment of NETest Clinical Utility in a U.S. Registry-Based Study. NETs, PFS
50  2018 Bilateral orbital soft tissue metastases from Renal Neuroendocrine Tumor: successful Theranostic application of 68Ga/177Lu-DOTATATE with improvement of vision. CgA, Lu, PRRT
51  2018 Bronchial carcinoid in anomalous right upper bronchus: a "patient-tailored" bronchoplasty resection technique. BC
52  2018 Capecitabine and Temozolomide in Neuroendocrine Tumor of Unknown Primary. CAPTEM
53  2018 Changes in biodistribution on 68Ga-DOTA-Octreotate PET/CT after long acting somatostatin analogue therapy in neuroendocrine tumour patients may result in pseudoprogression. CgA, GaTate, SSA
54  2018 Characterization of 111In-labeled Glucose-Dependent Insulinotropic Polypeptide as a Radiotracer for Neuroendocrine Tumors. GIP
55  2018 Chromogranin A and neuron-specific enolase in neuroblastoma: Correlation to stage and prognostic factors. CgA, CgB, GN, NB, NSE
56  2018 Clinical outcomes of patients with G1/G2 neuroendocrine tumors arising from foregut or hindgut treated with somatostatin analogs: a retrospective study. ORR, PFS, SSA
57  2018 Clusterin in Neuroendocrine Epithelial Neoplasms: Absence of Expression in a Well-differentiated Tumor Suggests a Jejunoileal Origin. NEC
58  2018 Contribution of Human papillomavirus in neuroendocrine tumors from a series of 10,575 invasive cervical cancer cases. EM, HPV, ICC, IHC
59  2018 Cost-effectiveness of everolimus for the treatment of advanced neuroendocrine tumours of gastrointestinal or lung origin in Canada. BSC, GI, LY, QALY, WTP
60  2018 CT follow-up in patients with neuroendocrine tumors (NETs): combined radiation and contrast dose reduction. ASIR, CA, CNR, CT, FBP, NETs, SNR
61  2018 Curative and palliative surgery in patients with neuroendocrine tumors of the gastro-entero-pancreatic (GEP) tract. GEP, NEC
62  2018 Demonstration of 68Ga-prostate-specific Membrane Antigen Uptake in Metastatic Pancreatic Neuroendocrine Tumor. PET-CT, PSMA
63  2018 Demonstration of Treatment Response to Trans-arterial Radio-embolization (TARE) on 68Ga-DOTANOC PET/CT in a Patient With Metastatic Neuroendocrine Tumor. TARE
64  2018 Diagnosis and management of Zollinger-Ellison syndrome in 2018. ZES
65  2018 Discovery of a neuroendocrine tumor of the caecum by mammary metastasis using 18F-DOPA-PET. ---
66  2018 Dosimetry methods and clinical applications in peptide receptor radionuclide therapy for neuroendocrine tumours: a literature review. PRRT, SRT
67  2018 Ectopic adrenocorticotropic hormone syndrome in a case of duodenal neuroendocrine tumor presenting with liver metastasis. ACTH, CS
68  2018 Ectopic insulinomas in the pelvis secondary to rectum neuroendocrine tumour. ---
69  2018 Endocytoscopic findings of colorectal neuroendocrine tumors (with video). ---
70  2018 Endoscopic Papillectomy for Synchronous Major and Minor Duodenal Papilla Neuroendocrine Tumors. ---
71  2018 Enzymatic degradation study of 111In-labeled minigastrin peptides using cathepsin B enzyme and AR42J cancer cell line for the development of neuroendocrine tumor imaging radiopharmaceuticals. CatB, CCK
72  2018 Establishment of the First Well-differentiated Human Pancreatic Neuroendocrine Tumor Model. ---
73  2018 Everolimus in Neuroendocrine Tumors of the Gastrointestinal Tract and Unknown Primary. GI, HR, PFS
74  2018 Everolimus is a new anti-cancer molecule: Metabolic side effects as lipid disorders and hyperglycemia. mTOR
75  2018 Fast non-enhanced abdominal examination protocols in PET/MRI for patients with neuroendocrine tumors (NET): comparison to multiphase contrast-enhanced PET/CT. SSR
76  2018 First report of concomitant pheochromocytoma and duodenal neuroendocrine tumour in a sporadic multiple endocrine neoplasia type 1. DEXA
77  2018 Flushing Disorders Associated with Gastrointestinal Symptoms: Part 2, Systemic Miscellaneous Conditions. MCAD
78  2018 Frequent BRAF mutations suggest a novel oncogenic driver in colonic neuroendocrine carcinoma. NEC, WES, WHO
79  2018 Gastric neuroendocrine neoplasm with late liver metastasis. g-NENs, LM
80  2018 Gastric neuroendocrine tumor arising from heterotopic pancreas. ---
81  2018 Gastrointestinal Neuroendocrine Tumor, Colon Adenocarcinoma, and Hyperparathyroidism: An Unorthodox Synchronism. ---
82  2018 Genomic profile of appendiceal goblet cell carcinoid is distinct compared to appendiceal neuroendocrine tumor and conventional adenocarcinoma. AC, GCC, LP
83  2018 Grading of pancreatic neuroendocrine neoplasms using pharmacokinetic parameters derived from dynamic contrast-enhanced MRI. DCE-MRI, NEC, pNENs, Ve, vp
84  2018 Health-related quality of life in MEN1 patients compared with other chronic conditions and the United States general population. CHF, COPD, HRQoL, MEN1, PHPT, PROMIS, RA
85  2018 Health-Related Quality of Life in Patients With Progressive Midgut Neuroendocrine Tumors Treated With 177Lu-Dotatate in the Phase III NETTER-1 Trial. HR, QOL, TTD
86  2018 Hepatic Resection for Non-functional Neuroendocrine Liver Metastasis: Does the Presence of Unresected Primary Tumor or Extrahepatic Metastatic Disease Matter? CI, HR, NF-NELM, OS
87  2018 High-Percentage Pathological Findings in Obese Patients Suggest that Esophago-gastro-duodenoscopy Should Be Made Mandatory Prior to Bariatric Surgery. EGD, GERD, GIST
88  2018 Identification and characterization of myocardial metastases in neuroendocrine tumor patients using 68Ga-DOTATATE PET-CT. ---
89  2018 Identification of Potential MR-Derived Biomarkers for Tumor Tissue Response to 177Lu-Octreotate Therapy in an Animal Model of Small Intestine Neuroendocrine Tumor. DCE, DWI, MR, SER
90  2018 Identifying tumor in pancreatic neuroendocrine neoplasms from Ki67 images using transfer learning. HPF, WHO
91  2018 Immunohistochemical analysis of OTP and NKX6.1 in neuroendocrine tumors of the lung and pancreas. AC, CT, FNA, IHC, LCNEC, NKX6.1, OTP, panNEC, PanNET, SCNEC
92  2018 Immunohistochemical CD73 expression status in gastrointestinal neuroendocrine neoplasms: A retrospective study of 136 patients. CD73, GI-NENs, MANEC, NEC, PD-1, PD-L1
93  2018 Impact of Tumor Burden on Quantitative [68Ga] DOTATOC Biodistribution. 1-TBU, BSA, CT, PET, SSTR, VOIs
94  2018 Incidence and prevalence of neuroendocrine tumors of the lung: analysis of a US commercial insurance claims database. APC, SEER
95  2018 Insulinoma-associated protein 1 immunostaining on cytology specimens: an institutional experience. IHC, TNEF
96  2018 Intestinal occlusion by stenotic neuroendocrine tumours of left colon and concomitant association with small bowel gastrointestinal stromal tumours: A case report. GIST
97  2018 Intra-caval Percutaneous Radiofrequency Ablation for a Neuroendocrine Tumor (NET) Metastasis in Transplanted Liver. NETs, RFA
98  2018 Iodine quantification to distinguish hepatic neuroendocrine tumor metastasis from hepatocellular carcinoma at dual-source dual-energy liver CT. DECT, HCC, LPR, NIU, ROC
99  2018 LanroNET - A Non-Interventional Prospective Study to Assess the Resource Utilisation and Cost of Lanreotide Autogel 120 mg in the Population of Polish Patients with Symptomatic Neuroendocrine Tumours. SD
100  2018 Large cell neuroendocrine carcinoma and adenocarcinoma of gallbladder with concomitant hepatitis C infection. ---